Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 8:00 pm Sale |
2024-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
Redmile Group LLC | 14,184,495 4.600% |
-1,191,702 (-7.75%) |
Filing History |
| 2025-02-14 4:15 pm Sale |
2024-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
PERCEPTIVE ADVISORS LLC | 24,245,952 8.100% |
-3,811,504 (-13.58%) |
Filing History |
| 2025-02-10 10:25 am Purchase |
2024-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
WELLINGTON MANAGEMENT CO LLP | 28,461,994 9.500% |
4,497,950 (+18.77%) |
Filing History |
| 2025-02-05 1:23 pm Purchase |
2024-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
BLACKROCK INC BLK |
27,904,336 9.300% |
4,918,894 (+21.40%) |
Filing History |
| 2024-11-14 9:00 pm Sale |
2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD |
Redmile Group LLC | 15,376,197 5.100% |
-6,581,729 (-29.97%) |
Filing History |
| 2024-11-14 11:37 am Purchase |
2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 15,582,962 5.300% |
15,582,962 (New Position) |
Filing History |
| 2024-11-14 09:31 am Sale |
2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD |
AVORO CAPITAL ADVISORS LLC | 23,175,000 7.800% |
-4,225,000 (-15.42%) |
Filing History |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD |
WELLINGTON MANAGEMENT CO LLP | 23,964,044 8.080% |
8,774,020 (+57.76%) |
Filing History |
| 2024-10-07 1:24 pm Sale |
2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD |
J P MORGAN CHASE & CO JPM |
12,823,682 4.300% |
-4,678,998 (-26.73%) |
Filing History |
| 2024-02-14 4:38 pm Purchase |
2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
PERCEPTIVE ADVISORS LLC | 28,057,456 9.600% |
414,539 (+1.50%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
Redmile Group LLC | 21,957,926 7.300% |
-6,641,568 (-23.22%) |
Filing History |
| 2024-02-14 09:22 am Purchase |
2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
AVORO CAPITAL ADVISORS LLC | 27,400,000 9.300% |
600,000 (+2.24%) |
Filing History |
| 2024-02-13 4:58 pm Purchase |
2023-12-29 | 13G | Amicus Therapeutics, Inc. FOLD |
The Vanguard Group | 28,492,486 9.720% |
1,954,115 (+7.36%) |
Filing History |
| 2024-02-08 10:05 am Purchase |
2023-12-29 | 13G | Amicus Therapeutics, Inc. FOLD |
WELLINGTON MANAGEMENT CO LLP | 15,190,024 5.180% |
7,082,677 (+87.36%) |
Filing History |
| 2024-01-26 11:49 am Purchase |
2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
BLACKROCK INC BLK |
22,985,442 7.800% |
2,851,450 (+14.16%) |
Filing History |
| 2024-01-08 09:09 am Purchase |
2023-12-29 | 13G | Amicus Therapeutics, Inc. FOLD |
J P MORGAN CHASE & CO JPM |
17,502,680 5.900% |
4,040,756 (+30.02%) |
Filing History |
| 2023-12-08 4:31 pm Sale |
2023-11-30 | 13G | Amicus Therapeutics, Inc. FOLD |
MORGAN STANLEY MS |
12,303,701 4.200% |
-5,281,315 (-30.03%) |
Filing History |
| 2023-02-14 4:16 pm Purchase |
2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
Redmile Group LLC | 28,599,494 9.900% |
194,452 (+0.68%) |
Filing History |
| 2023-02-14 2:31 pm Purchase |
2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
PERCEPTIVE ADVISORS LLC | 27,642,917 9.800% |
286,874 (+1.05%) |
Filing History |
| 2023-02-14 09:35 am Purchase |
2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
AVORO CAPITAL ADVISORS LLC | 26,800,000 9.500% |
8,300,000 (+44.86%) |
Filing History |